The objective of this toolkit is to provide guidance on the disclosure process of an HIV status for pediatric and adolescent populations. This document contains tools for use in clinical practice to build the capacity of health care workers, caregivers, and pediatric and adolescent patients themselves in assisting with and delivering successful and informed disclosure.
This toolkit was developed to build capacity of technical assistance providers and managers at the service delivery level. It contains a suite of existing tools and resources to address site-level health workforce performance and productivity problems impacting HIV service delivery.
Lopinavir/ritonavir (LPV/r) pellets are a new formulation of a pediatric HIV medicine. The LPV/r Pellet Toolkit provides information on how to implement rollout of LPV/r pellets into the national health care system in the Rollout Planning and Management section.
The HIV New Product Introduction Toolkit provides Ministries of Health (MoHs) and implementing partners with the tools necessary to evaluate the adoption and introduction of new products in their local context.
This toolbox is for governments, nongovernmental organizations, and private researchers who wish to implement IBBS surveys for key populations at higher risk for HIV infection. The toolbox features two methods
The U.S. government and other investors in programs to improve the well-being of orphans and vulnerable children (OVC) want to know the impact of their funding. Meaningful evaluation requires measurable results.